Did Jim Cramer Hit or Miss On These 13 Stock Predictions?

6. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Investors: 70

When a caller asked about Bristol-Myers Squibb Company (NYSE:BMY), Cramer responded negatively, citing weak pipeline prospects discussed at an earlier J.P. Morgan healthcare conference. Here’s what Jim Cramer said at the time:

“They told you when we were at J.P. Morgan that look, we don’t have the horses now, but the dividend is safe. I mean, what that was, was the crowd Clarion call to move out. At these prices I I still think the clarion call is on—feels a little like ‘fear me’.”

Cramer’s call was a miss, as the stock has risen by 13.28% since those comments.

However, he is increasingly more bullish on Bristol-Myers Squibb Company (NYSE:BMY) in recent episodes. Here’s what he said a few days ago:

“I’m going to say something that could get me in trouble, but I, I like the market at this level. I really do. But I’ve got to tell you, and Michael, you know I play it straight, I like Bristol Myers a lot more—BMY. I like it a lot more because the schizophrenia drug is on the come.”